Galecto, Inc. (GLTO)
NASDAQ: GLTO · Real-Time Price · USD
5.94
-0.02 (-0.34%)
At close: Nov 5, 2025, 4:00 PM EST
5.66
-0.28 (-4.71%)
After-hours: Nov 5, 2025, 7:40 PM EST
Galecto Market Cap
Galecto has a market cap or net worth of $7.87 million as of November 5, 2025. Its market cap has increased by 3.13% in one year.
Market Cap
7.87M
Enterprise Value
-2.27M
1-Year Change
3.13%
Ranking
Category
Stock Price
$5.94
Market Cap Chart
Since the IPO on October 29, 2020, Galecto's market cap has decreased from $368.78M to $7.87M, a decrease of -97.87%. That is a compound annual growth rate of -53.52%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 5, 2025 | 7.87M | 28.48% |
| Dec 31, 2024 | 6.12M | -68.63% |
| Dec 29, 2023 | 19.52M | -33.64% |
| Dec 30, 2022 | 29.42M | -61.57% |
| Dec 31, 2021 | 76.54M | -75.78% |
| Dec 31, 2020 | 316.01M | -14.31% |
| Oct 29, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 811.99B |
| Johnson & Johnson | 450.20B |
| AbbVie | 381.56B |
| UnitedHealth Group | 299.68B |
| AstraZeneca | 253.45B |
| Novartis AG | 240.68B |
| Abbott Laboratories | 218.75B |
| Novo Nordisk | 215.64B |